wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38750224-3BD5ED75-081E-462A-919F-3B76D13E5B20
Q38750224-3BD5ED75-081E-462A-919F-3B76D13E5B20
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38750224-3BD5ED75-081E-462A-919F-3B76D13E5B20
Small Molecule Survivin Inhibitor YM155 Displays Potent Activity Against Human Osteosarcoma Cells.
P2860
Q38750224-3BD5ED75-081E-462A-919F-3B76D13E5B20
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38750224-3BD5ED75-081E-462A-919F-3B76D13E5B20
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2e222f9202a3e1a13d8c36b90603dc85c4d8a882
P2860
A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer.